Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML

Acute myeloid leukemia (AML) is a deadly heterogeneous hematologic malignancy. Despite the well-characterized genetic characteristics and new promising targeted therapies for AML, the clinical outcome remains suboptimal. Galectin-9 (Gal-9) is a good potential target due to its immunosuppressive capa...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yongping, Xue, Song, Hao, Qi, Liu, Fuhong, Huang, Wenqiu, Wang, Jingbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176406/
https://www.ncbi.nlm.nih.gov/pubmed/34093826
http://dx.doi.org/10.7150/jca.53686

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176406/
https://www.ncbi.nlm.nih.gov/pubmed/34093826
http://dx.doi.org/10.7150/jca.53686

Ejemplares similares